G
Monte Rosa Therapeutics D
D
GLUE
4.73000
USD
0.09
(1.94%)
مغلق
حجم التداول
17,959
الربح لكل سهم
0
العائد الربحي
-
P/E
40
حجم السوق
290,941,453
الأخبار المقالات
العنوان: Monte Rosa Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.